Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $1.5352W HIGH $8.48
Volume
63.60 K
Value Traded
79.99 M
Short % Float
0.03%
Days to Cover
4.3
+13.92%Week
+11.62%1 Month
+14.51%3 Month
-11.6%6 Month
-70.31%5 Year
-70.31%All Time
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
355.94 M
EPS (TTM)
0.15
P/E Ratio
14.52
Ent. Value
7.40 M
Total Shares
158.19 M
Float Shares
144.54 M
Insiders
8.63%
Institutions
0.01%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
PoA blends historical approval base rates, trial design score and FDA review track record.
ZJYL Catalyst Timeline
Dated clinical, regulatory and corporate events for JIN MEDICAL INTERNATIONAL LTD.
Catalyst Timeline
Dated clinical, regulatory & corporate events for JIN MEDICAL INTERNATIONAL LTD.
21Total events
0Upcoming
4Tier-1 (high impact)
2023 to 2026Coverage
Event history 21
▲Manufacturing MilestoneCMC / Inspection
Chuzhou new factory expected to launch full capacity production
▼Reverse Stock SplitCorporate
Shareholders approved proposal authorizing board to implement future reverse stock splits
▲Manufacturing MilestoneCMC / Inspection
Production launched at Plant No. 3 of Zhongjin Anhui intelligent manufacturing facility in Chuzhou
▲Manufacturing MilestoneCMC / Inspection
Chuzhou facility to achieve full annual production capacity
▲Manufacturing MilestoneCMC / Inspection
Initiation of construction of new manufacturing facility in Chuzhou, China
▲Partnership / LicenseCorporate
Secured RMB66 million orders from Conlo Industrial Development
▲Product LaunchPost-Market
Successful launch of MINI micro-hyperbaric oxygen chamber and hydrogen generation machine
▼Equity OfferingCorporate
Underwriters partially exercise over-allotment option to purchase additional 47,355 ordinary shares at $8.00 per share
●IpoCorporate
Pricing of initial public offering of 1,000,000 ordinary shares at $8.00 per share
Past FDA Catalysts and PDUFA Decisions
How ZJYL actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
JIN MEDICAL INTERNATIONAL LTD. is a medical device company. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every ZJYL program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| No insider trades match the selected filters. | |||||
Hedge Fund 13F Activity
Hedge Funds invested in ZJYL
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in ZJYL for Q2 2026. | ||||
Ownership Trends
ZJYL Short Interest
Shares sold short, counted twice a month.
0.03%
Short % of Float
of tradable shares sold short
49.1K
Shares Sold Short
-29.8% vs prior count
4.3 Moderate
Days to Cover
trading days of normal volume to buy every short share back
11.3K
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How ZJYL ranks across every disease it competes in
Competitive Position is a premium feature
See how ZJYL ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialZJYL News
ZJYL▼ -4.3%today
Jin Medical Showcases Innovation Across Four Global Industry Expos: Lightweight Rehabilitation Assistive Line Draws Broad Market Attention
Jin Medical International Ltd. (ZJYL) exhibited new wheelchairs at four global expos from August to September 2026. The company highlighted lightweight carbon fiber and smart electric models in Suzhou, Beijing, Nanning, and Düsseldorf. Distributors in Europe and Asia praised the designs and discussed potential partnerships. These engagements support the firm's strategy to expand its international dealer network.
Read more →ZJYL▲ +13.9%on this news· ran to +51% by day 3
JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results
JIN MEDICAL INTERNATIONAL LTD. reported a 9.7% decline in total revenue for the first half of fiscal year 2026, totaling $8.9 million. Despite this, the company saw improvements in gross margin and stable sales from core wheelchair products. The net loss was $0.2 million, attributed to decreased sales orders from a major customer affected by foreign exchange fluctuations. The company plans to focus on strengthening its product portfolio and expanding its customer base.
Read more →ZJYLJin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement
Jin Medical International Ltd. has announced its compliance with Nasdaq's minimum bid price requirement after its shares maintained a closing price of at least $1.00 for more than ten consecutive business days. The company, which specializes in rehabilitation medical equipment, plans to continue focusing on its core operations and strategic initiatives. This development reflects positively on Jin Medical's market position.
Read more →ZJYLJin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance Initiative
Jin Medical International Ltd. announced a 1-for-20 share combination as part of a strategic initiative to maintain Nasdaq compliance and strengthen its long-term capital structure. Effective March 16, 2026, this stock combination follows the approval from a recent extraordinary general meeting. The reclassification of shares will reduce both Class A and Class B shares significantly, aimed at enhancing governance and financial health. The company continues to operate with established plans for extensive manufacturing capabilities in China.
Read more →ZJYLJin Medical CEO Fireside Chat
Jin Medical International Ltd. hosted a CEO Fireside Chat on February 2, 2026, where CEO Dr. Erqi Wang discussed the company's strategic priorities and long-term growth plans. Key points included the implementation of reverse stock splits to regain Nasdaq compliance and improve market perception. The company plans to focus on disciplined capital allocation, enhancing manufacturing efficiency, and the strategic importance of their new Chuzhou facility expected to launch full production by April 2026. Overall, management aims to navigate industry challenges while prioritizing sustainable growth in the coming years.
Read more →ZJYLJin Medical International Ltd. To Host Management
Jin Medical International Ltd. announced that its CEO and management team will host a fireside chat on February 1, 2026, focusing on strategic priorities and growth opportunities. The company also revealed the launch of its redesigned corporate website, improving accessibility for stakeholders. Jin Medical, a prominent player in the rehabilitation medical equipment sector, is actively expanding its operations with a new larger manufacturing facility in Anhui Province.
Read more →ZJYLJin Medical International Ltd. To Host Management Fireside Chat
Jin Medical International Ltd. will host a fireside chat on February 1, 2026, led by its CEO and management team. The discussion aims to provide insights into the company's strategic priorities and growth plans. Additionally, Jin Medical has launched an updated corporate website where the chat will be webcast. The company is expanding its manufacturing capabilities in China.
Read more →ZJYLJin Medical Announces the Official Commencement Date of Chuzhou Facility
Jin Medical International Ltd. has announced the commencement of its new manufacturing facility in Chuzhou, Anhui Province, China, expected to begin full production by April 2026. The facility will focus on manufacturing mid-to-high-end electric wheelchairs and mobility scooters, enhancing Jin Medical's capacity to meet growing global demand. Completion of this project is aligned with the company's strategic goals of optimizing production capacity and improving supply chain resilience. The location offers significant geographic advantages within the manufacturing hub of the Yangtze River Delta.
Read more →ZJYLJin Medical International Ltd. Management Plans
Jin Medical International Ltd. has announced that its management team will host a fireside chat on February 1, 2026, to discuss the company's strategic priorities and capital structure. The discussion will address recent market developments while providing transparency into management's decision-making process. Jin Medical emphasizes its strong liquidity position and is exploring various strategic options to strengthen its competitive stance in the rehabilitation medical equipment market.
Read more →ZJYLJIN MEDICAL INTERNATIONAL LTD. No. 33 Lingxiang Road, Wujin District Changzhou City, Jiangsu Province People's Republic of China NOTICE OF 2026 EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS To Be Held at 10:00 p.m
Jin Medical International Ltd. announced an extraordinary general meeting of shareholders scheduled for January 30, 2026, to discuss several key proposals. These include increasing the authorized share capital, the creation of dual-class shares, and potential consolidations of shares. Shareholders will also consider the adoption of a new equity incentive plan. Importantly, the Board unanimously recommends approval of all proposals to enhance the company's capital structure and governance.
Read more →ZJYL▼ -5.6%on this news· ran to +41% by day 3
JIN MEDICAL INTERNATIONAL LTD. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS March 31
Jin Medical International Ltd. has reported its unaudited condensed consolidated balance sheets as of March 31, 2025. The company showed an increase in current assets, notably a rise in cash reserves, but faced ongoing struggles with declining revenues and a net loss for the period. The company's total liabilities also increased, leading to a significant comprehensive loss attributed to challenges in foreign currency translation. Despite maintaining a positive cash flow from operating activities, the financial outlook indicates underlying issues that could impact future performance.
Read more →ZJYLJin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing Facility
Jin Medical International Ltd. has officially launched production at Plant No. 3 in Chuzhou, Anhui, China. This new facility is part of the company's strategy to accelerate global delivery of rehabilitation medical equipment, with a production capacity of 200,000 units per year. Emphasizing intelligent manufacturing techniques, Jin Medical aims to enhance its supply chain and contribute to meeting diverse global health needs. The company's product range includes wheelchairs and wellness devices, targeting international markets including Istanbul, Jerusalem, and Tokyo.
Read more →ZJYLJin Medical International Ltd. - Nasdaq Minimum Bid Price Non-Compliance
Jin Medical International Ltd. announced it received a deficiency notice from Nasdaq for failing to maintain the minimum bid price of $1.00 for its shares. The compliance period granted by Nasdaq is 180 days, and the Company aims to regain compliance during this time. If the bid price fails to reach the minimum within this period, additional time may be available, but the Company still faces potential delisting risks. Operations continue, with the Company examining options to address the situation.
Read more →ZJYLJin Medical Accelerates Chuzhou Facility Construction to Unlock Annual Production Capacity of RMB 300 Million
Jin Medical International Ltd. is making significant advancements in the construction of its Chuzhou manufacturing facility, which is projected to achieve an annual production capacity of RMB 300 million. The facility aims to produce mid-to-high-end electric wheelchairs and mobility scooters, with trial production set for May 2025 and full completion by October 2025. This expansion is aligned with the growing demand for assistive devices due to global aging, bolstering Jin Medical's manufacturing capabilities and market position.
Read more →ZJYLConstruction of JinMed's New Facility Begins in Chuzhou, China Chuzhou City, China
Jin Medical International Ltd. has announced the initiation of construction for a new manufacturing facility in Chuzhou City, Anhui Province, China. This facility aims to serve as a high-end production site for wheelchairs, electric wheelchairs, and other healthcare products. The new site is expected to enhance JinMed's production capacity and innovative offerings in the assistive technologies industry. The facility is targeted to begin operations in 2025, marking a significant step forward for the company's growth and technological advancement.
Read more →ZJYLJIN MEDICAL INTERNATIONAL LTD. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS March 31
Jin Medical International Ltd. released its unaudited condensed consolidated financial statements for March 31, 2024. The company reported total assets of approximately $41.16 million, marking an increase from $32.90 million in the previous year. Notably, net income attributable to Jin Medical increased to around $1.79 million. The firm continues to show resilience in its operations, despite minor fluctuations in revenue and expenses.
Read more →ZJYL▼ -13%on this news
JIN MEDICAL INTERNATIONAL LTD. No. 33 Lingxiang Road, Wujin District Changzhou City, Jiangsu Province People's Republic of China NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS To Be Held at 9.30 a.m. Beij
Jin Medical International Ltd. is holding an extraordinary general meeting of shareholders on January 30, 2024. The meeting will address a proposal to subdivide issued and unissued shares, transforming each share into twenty new shares with a reduced par value. Shareholders of record as of January 12, 2024, are eligible to vote, and proxy materials have been sent out to ensure participation. The Board has unanimously recommended approval of the proposals.
Read more →ZJYL▲ +11.9%on this news· ran to +275% by day 3
JIN MEDICAL INTERNATIONAL LTD. Enters into Memorandum of Understanding to Acquire Medical Equipment Sharing Platform Changzhou City, China
JIN MEDICAL INTERNATIONAL LTD. has signed a Memorandum of Understanding to explore the acquisition of Jiangsu Zhongjin Kanglu, a company specializing in medical equipment sharing. This acquisition aims to enhance healthcare service access through better equipment availability. A due diligence process is set to evaluate the acquisition's feasibility by the end of December 2023, with detailed negotiations expected to begin in March 2024. However, there is no guarantee that the acquisition will proceed as planned.
Read more →ZJYLJIN MEDICAL INTERNATIONAL LTD. Empowers "Lao Le Hui" Assisted Bathing Project with Portable Nano-thermal Therapy Bath Changzhou City, China
Jin Medical International Ltd. has announced its collaboration with the 'Lao Le Hui' Assisted Bathing Project to provide 1,000 portable nano-thermal therapy baths. This initiative, aimed at improving care for disabled and semi-disabled elderly individuals in Shanghai, targets assistance for 100,000 people and training 2,000 attendants over the next two years. The project emphasizes community involvement and aims to enhance the quality of elderly care through advanced bathing technology, which promises a more comfortable bathing experience. Chairman Wang Erqi expressed commitment to supporting the project's goals and expanding its reach.
Read more →ZJYL▲ +9.8%on this news· ran to +24% by day 3shared move
JIN MEDICAL INTERNATIONAL LTD. Secures RMB66 Million in Orders for Innovative Micro-Hyperbaric Oxygen Chamber Equipment Changzhou City, China
Jin Medical International Ltd. announced the acquisition of RMB 66 million in orders for their innovative Micro-Hyperbaric Oxygen Chamber equipment from Conlo Industrial Development. This order includes 200 units each of the S-type and M-type chambers, which are designed for therapeutic use. The strategic partnership aims to meet the increasing demand in the healthcare sector over the next three years, with plans to supply a total of 20,000 oxygen chambers for both human and pet use. The chambers are anticipated to enhance health and well-being through various therapeutic applications.
Read more →About JIN MEDICAL INTERNATIONAL LTD.
BIOPHARMAWATCH ELITE PLUS
Trade the next ZJYL catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime